Archive · 3 Jun 2025
IISc. Develops Nanozyme to Combat Excessive Blood Clotting
Researchers at the Indian Institute of Science (IISc) have created a tiny material called a nanozyme that helps stop blood clots from forming too much.
Blood clots are important to stop bleeding, but too many clots can cause problems.
The nanozyme acts like a natural helper in the body, reducing stress that causes clots.
They tested it on mice and found it helped them survive.
The scientists are now hoping to test this nanozyme in humans to help prevent strokes and other problems caused by excess blood clotting.
This nanozyme is made of vanadium and works to control the levels of molecules that can cause too much clotting.
IISc. researchers developed a nanozyme to address abnormal blood clotting.
The nanozyme is a metal-based material that mimics natural antioxidant enzymes.
The nanozyme works by controlling reactive oxidative molecules.
Spherical-shaped vanadium pentoxide nanozymes were found to be most efficient.
Injected nanozyme in mice significantly reduced thrombosis and increased survival rates.
- Who
- Researchers at IISc.
- What
- Developed a nanozyme to prevent excess blood clotting.
- When
- June 03, 2025
- Where
- Indian Institute of Science (IISc.)
- Why
- To prevent excess blood clotting and thrombosis.
- Nanozyme Material
- Vanadium pentoxide (V2O5)
- Nanozyme Function
- Mimics glutathione peroxidase
- Primary Benefit
- Preventing excess clotting
- Observed Effect
- Increased survival rates in mice
- Future Research Focus
- Preventing ischemic stroke